Guanidyl-Rich Poly(β Amino Ester)s for Universal Functional Cytosolic Protein Delivery and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Cas9 Ribonucleoprotein Based Gene Editing
Source abstract
Abstract
Protein therapeutics are highly promising for complex disease treatment. However, the lack of ideal delivery vectors impedes their clinical use, especially the carriers for in vivo delivery of functional cytosolic protein. In this study, we modified poly(β amino ester)s (PAEs) with a phenyl guanidine (PG) group to enhance their suitability for cytosolic protein delivery. The effects of the PG group on protein binding, cell internalization, protein function protection, and endo/lysosomal escape were systematically evaluated. Compared to the unmodified PAEs (L3), guanidyl rich PAEs (L3PG) presented superior efficiency of protein binding and protein internalization, mainly via clathrin-mediated endocytosis. In addition, both PAEs showed robust capabilities to deliver cytosolic proteins with different molecular weight (ranging from 30 to 464 kDa) and isoelectric points (ranging from 4.3 to 9), which were significantly improved in comparison with the commercial reagents of PULsin and Pierce Protein Transection Reagent. Moreover, L3PG successfully delivered Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Cas9 ribonucleoprotein (RNP) into HeLa cells expressing green fluorescent protein (GFP) and achieved more than 80% GFP expression knockout. These results demonstrated that guanidyl modification on PAEs can enhance its capabilities for intracellular delivery of cytosolic functional proteins and CRISPR/Cas9 ribonucleoprotein. The guanidyl-rich PAEs are promising nonviral vectors for functional protein delivery and potential use in protein and nuclease-based gene editing therapies.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Plant Virus Research Studies · Toxin Mechanisms and Immunotoxins
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Charles Institute of Dermatology, School of Medicine, University College Dublin, D04 V1W8 Dublin, Ireland
Research and Clinical Translation Center of Gene Medicine and Tissue Engineering, School of Public Health, Anhui University of Science and Technology, Huainan 232001, China
Funding
Science Foundation Ireland · China Scholarship Council
References (51)
Show source-provided references
1. 10.1038/nrd239910.1038/nrd2399 ↗
2. 10.1016/S0140-6736(82)90548-710.1016/S0140-6736(82)90548-7 ↗
3. 10.1038/jid.2013.1010.1038/jid.2013.10 ↗
4. 10.1002/1097-0142(19931201)72:11+<3453::AID-CNCR2820721612>3.0.CO;2-#10.1002/1097-0142(19931201)72:11+<3453::AID-CNCR2820721612>3.0.CO;2-# ↗
5. 10.1038/mt.2008.11410.1038/mt.2008.114 ↗
6. 10.1089/hum.2011.08710.1089/hum.2011.087 ↗
7. 10.1126/scitranslmed.aaj201310.1126/scitranslmed.aaj2013 ↗
8. 10.1038/s41467-022-30896-210.1038/s41467-022-30896-2 ↗
9. 10.1016/j.addr.2021.11408710.1016/j.addr.2021.114087 ↗
10. 10.1016/j.stem.2019.04.00110.1016/j.stem.2019.04.001 ↗
11. 10.1073/pnas.152024411310.1073/pnas.1520244113 ↗
12. 10.1016/j.biomaterials.2018.03.01110.1016/j.biomaterials.2018.03.011 ↗
13. 10.1186/s12951-019-0452-810.1186/s12951-019-0452-8 ↗
14. 10.1126/sciadv.aaw892210.1126/sciadv.aaw8922 ↗
15. 10.1126/sciadv.aay325510.1126/sciadv.aay3255 ↗
16. 10.1038/s41434-021-00282-610.1038/s41434-021-00282-6 ↗
17. 10.1021/acscentsci.0c0164810.1021/acscentsci.0c01648 ↗
18. 10.1038/s41551-017-0137-210.1038/s41551-017-0137-2 ↗
19. 10.1021/acsami.9b1233510.1021/acsami.9b12335 ↗
20. 10.1126/sciadv.abp943510.1126/sciadv.abp9435 ↗
21. 10.1002/jev2.1207610.1002/jev2.12076 ↗
22. 10.1021/acs.bioconjchem.8b0079910.1021/acs.bioconjchem.8b00799 ↗
23. 10.1039/C0CS00003E10.1039/C0CS00003E ↗
24. 10.1039/C6CS00636A10.1039/C6CS00636A ↗
25. 10.1021/jacs.9b1275910.1021/jacs.9b12759 ↗
26. 10.1002/adtp.20190004110.1002/adtp.201900041 ↗
27. 10.1021/acscentsci.9b0050110.1021/acscentsci.9b00501 ↗
28. 10.1021/acsami.1c2200910.1021/acsami.1c22009 ↗
29. 10.1016/j.jconrel.2020.01.05610.1016/j.jconrel.2020.01.056 ↗
30. 10.1021/acs.bioconjchem.8b0075310.1021/acs.bioconjchem.8b00753 ↗
31. 10.1021/acs.nanolett.6b0495510.1021/acs.nanolett.6b04955 ↗
32. 10.1038/s41467-018-03779-810.1038/s41467-018-03779-8 ↗
33. 10.1016/j.biomaterials.2018.08.02310.1016/j.biomaterials.2018.08.023 ↗
34. 10.1016/j.biomaterials.2014.03.04010.1016/j.biomaterials.2014.03.040 ↗
35. 10.1021/ar400055410.1021/ar4000554 ↗
36. 10.1002/ange.20211672210.1002/ange.202116722 ↗
37. 10.1021/ja001538810.1021/ja0015388 ↗
38. 10.1073/pnas.040721810110.1073/pnas.0407218101 ↗
39. 10.1126/sciadv.160010210.1126/sciadv.1600102 ↗
40. 10.1016/j.addr.2021.11384210.1016/j.addr.2021.113842 ↗
41. 10.1126/sciadv.abj062410.1126/sciadv.abj0624 ↗
42. 10.1038/s41565-023-01378-310.1038/s41565-023-01378-3 ↗
43. 10.1016/j.actbio.2022.08.07010.1016/j.actbio.2022.08.070 ↗
44. 10.1021/acsmacrolett.3c0015510.1021/acsmacrolett.3c00155 ↗
45. 10.1021/acsnano.1c0499610.1021/acsnano.1c04996 ↗
46. 10.1007/s11120-013-9823-410.1007/s11120-013-9823-4 ↗
47. 10.1021/acsnano.8b0548210.1021/acsnano.8b05482 ↗
48. 10.1111/j.1365-2818.2006.01706.x10.1111/j.1365-2818.2006.01706.x ↗
49. 10.1038/nbt0492-40510.1038/nbt0492-405 ↗
50. 10.1002/(SICI)1097-0290(19991020)65:2<201::AID-BIT10>3.0.CO;2-H10.1002/(SICI)1097-0290(19991020)65:2<201::AID-BIT10>3.0.CO;2-H ↗
51. 10.1038/s41467-019-12906-y10.1038/s41467-019-12906-y ↗